返回
Hua Medicine（02552.HK）價格
02552.HK 股價走勢圖
HUA MEDICINE-B (02552.HK)
Hua Medicine
HK$3.12
0.64%
$0.02
休市： Feb 16, 12:00:00 HKT
關鍵數據
前收市價
$3.04
開盤價
$3.1
當日範圍
$2.99 - $3.12
52週區間
$1.24 - $4.95
交易量
--
平均成交量
3.5M
每股盈餘 (TTM)
1.21
股息收益率
--
市值
$3.0B
什麼是 HUA MEDICINE-B？
Hua Medicine Ltd. provides drug discovery and development services. The company is headquartered in Shanghai, Shanghai and currently employs 285 full-time employees. The company went IPO on 2018-09-14. The firm is also engaged in the commercialization of HuaTangNing products. The Company’s main product pipeline dorzagliatin or HMS5552 is a glucokinase activator or GKA, designed to control the progressive degenerative nature of diabetes by restoring glucose homeostasis in Type 2 diabetes. The firm mainly conducts its business in the domestic market.
